Skip to content
healthcare.dev

terazosin

NDC 68788-8171, terazosin, capsule, from Preferred Pharmaceuticals Inc..

Product NDC
68788-8171
Status
Listed
Labeler
Preferred Pharmaceuticals Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075614
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68788-8171 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERAZOSIN HYDROCHLORIDE2 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
68788-8171-36878881710330 CAPSULE in 1 BOTTLE (68788-8171-3)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a78f74ce-1c53-41ea-878e-13674db10a67

Use it

Look up 68788-8171 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68788-8171 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68788-8171. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.